Received Sep 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | UNK | — | — |
It was minor symptoms, flu; flu and achy like symptoms; This is a spontaneous report received from a Consumer or other non HCP from medical information team. An 80-year-old female patient received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), in 2025 as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE NUMBER UNKNOWN, SINGLE), for Covid-19 immunisation. The following information was reported: INFLUENZA (non-serious) with onset 2025, outcome "unknown", described as "It was minor symptoms, flu "; PAIN (non-serious) with onset 2025, outcome "unknown", described as "flu and achy like symptoms". Additional information: Caller inquired about the appropriate interval for receiving a COVID-19 vaccine booster (2025-2026 formula) and its availability near their location. Consumer reported that she is working with little children and she hasn't had a COVID 19 vaccine since May2025. How soon she should get it? Last she heard it had to be 6 months. She is reluctant to work at a school at 80 years old with multiple physical conditions without having a recent Covid shot. She has done OK with the Pfizer vaccine, except for a little bit at one time. She don't really remember what happened but it was earlier this year, either in May2025 or 4 months before that. It was minor symptoms, flu and achy like symptoms, for 1 day. She never had it before and always had Pfizer vaccine." Replied COMIRNATY is administered as a single dose for individuals 5 years of age and older. For individuals previously vaccinated with any COVID-19 vaccine, administer the dose of COMIRNATY at least 2 months after the last dose of COVID-19 vaccine. Comirnaty (2025-2026 Formula) is available in pharmacies, hospitals, and clinics. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.